Scor SE

Environmental & Social Information • Jan 13, 2011

Press Release (p.1/2) 13 January 2011 N° 02 – 2011

Co For further information, please contact: Jean-Charles Simon / Géraldine Fontaine +33 (0) 1 46 98 73 17 Communications and Public Affairs Antonio Moretti +44 (0) 203 207 8562 Investor Relations Director

SCOR supports research into HIV through a partnership with the Pierre and Marie Curie University

SCOR Global Life, SCOR's Life reinsurance branch, has signed a partnership agreement with the Pierre and Marie Curie University in France, in order to support research into the auto immune deficiency virus (HIV) led by the Pierre and Marie Curie University team at the Pitié-Salpêtrière hospital. The team is headed by Professor Brigitte Autran. Professor Autran and her team are recognised around the world for their work on the immunity controlling the HIV infection and the development of viral eradication strategies.

This partnership was formally sealed yersterday in the presence of Professor Autran, head of the "Antiviral and vaccinal immunity and immunogenetics" team at the joint UPMC/INSERM "Immunity and infection" laboratory, of Jean-Charles Pomerol, President of the Pierre and Marie Curie University, of Nicolas Crespelle, President of the Pierre and Marie Curie University Partnership Foundation, of Denis Kessler, Chairman and CEO of SCOR, and of Gilles Meyer, CEO of SCOR Global Life.

SCOR Global Life places particular importance on research and innovation, notably through its four international research and development centres dedicated to the enhancement of expertise in the field of Life and Health risks. These risk centres are: CIRDAD (Long-Term Care Insurance), CERDALM (Longevity and Mortality Insurance), CERDI (Disability and Critical Illness Insurance), and CREDISS (Medical Selection and Claims). SCOR Global Life's research and development centres conduct a number of research projects in partnership with universities and foundations, notably on cardiovascular risks with the ASSMANN Foundation and on Alzheimer's disease with the IFRAD Foundation.

* * *

SCOR SE 1, av. du Général de Gaulle 92074 Paris La Défense Cdx France Tél + 33 (0) 1 46 98 70 00 Fax + 33 (0) 1 47 67 04 09 www.scor.com RCS Nanterre B 562 033 357 Siret 562 033 357 00020 Société européenne au capital de 1 478 740 032 euros

Press Release (p.2/2) 13 January 2011 N° 02 – 2011

Forward-looking statements

SCOR does not communicate "profit forecasts" in the sense of Article 2 of (EC) Regulation n°809/2004 of the European Commission. Thus, any forward-.looking statements contained in this communication should not be held as corresponding to such profit forecasts. Information in this communication may include "forward-looking statements", including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives, based on certain assumptions and include any statement which does not directly relate to a historical fact or current fact. Forward-looking statements are typically identified by words or phrases such as, without limitation, "anticipate", "assume", "believe", "continue", "estimate", "expect", "foresee", "intend", "may increase" and "may fluctuate" and similar expressions or by future or conditional verbs such as, without limitations, "will", "should", "would" and "could." Undue reliance should not be placed on such statements, because, by their nature, they are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, on the one hand, to differ from any results expressed or implied by the present communication, on the other hand.

Please refer to SCOR's document de référence filed with the AMF on 3 March 2010 under number D.10-00085 (the "Document de Référence"), for a description of certain important factors, risks and uncertainties that may affect the business of the SCOR Group. As a result of the extreme and unprecedented volatility and disruption of the current global financial crisis, SCOR is exposed to significant financial, capital market and other risks, including movements in interest rates, credit spreads, equity prices, and currency movements, changes in rating agency policies or practices, and the lowering or loss of financial strength or other ratings.

SCOR SE

1, av. du Général de Gaulle 92074 Paris La Défense Cdx France Tél + 33 (0) 1 46 98 70 00 Fax + 33 (0) 1 47 67 04 09 www.scor.com RCS Nanterre B 562 033 357 Siret 562 033 357 00020 Société européenne au capital de 1 478 740 032 euros